FLUTIFLO FT NASAL SPR 7 GM

FLUTIFLO FT NASAL SPR 7 GM works by reducing inflammation in the airways and nasal passages, thereby relieving symptoms such as congestion, sneezing, and difficulty breathing.

FLUTIFLO FT NASAL SPR 7 GM exerts its therapeutic effects by acting as a potent anti-inflammatory agent. When administered as an inhaler or nasal spray, it targets the airways or nasal passages, respectively. The medication binds to glucocorticoid receptors within cells, triggering a cascade of biochemical reactions that result in the inhibition of inflammatory processes. FLUTIFLO FT NASAL SPR 7 GM suppresses the production of pro-inflammatory cytokines, reduces the recruitment of inflammatory cells, and inhibits the release of chemical mediators involved in allergic responses. These actions help decrease swelling, mucus production, and airway hyperresponsiveness. By reducing airway inflammation, FLUTIFLO FT NASAL SPR 7 GM improves breathing, alleviates symptoms like coughing, wheezing, and shortness of breath, and helps prevent asthma exacerbations. In allergic rhinitis, it attenuates nasal congestion, sneezing, itching, and rhinorrhea. FLUTIFLO FT NASAL SPR 7 GM local action minimizes systemic exposure, thereby reducing the risk of systemic side effects associated with corticosteroid use.